CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Abroad (travel likely)Recruiting

Conditions

Multiple Myeloma · Multiple Myeloma Progression · Monoclonal Gammopathy of Undetermined Significance (MGUS) · Smoldering Multiple Myeloma (SMM) · Plasma Cell Disorders

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Atrium Health Levine Cancer, Charlotte, North Carolina, United States
Contact: Study coordinator (Margarita Dzhanumova) · margarita.dzhanumova@atriumhealth.org · 704-754-3768
Contact: Principal Investigator (Manisha Bhutani, MD)

Study leads

Manisha Bhutani, MD
Principal Investigator
Atrium Health Wake Forest Baptist Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Detroit, United States · Lansing, United States

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Scottsdale, United States · Los Angeles, United States

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1

Iowa City, United States

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma · Cancer

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States · Charlotte, United States